한국어
English
日本語
中文(简体)Primovist Injection
132.717mg
Prescription medication · Combination
Bayer Korea Co., Ltd.
Eobi-DTPA is a contrast agent used in medical imaging.
MFDS ingredient code M222614
Eobi-DTPA is a contrast agent that combines with radioactive isotopes to provide clear images of internal body structures during imaging. It is primarily used to enhance the contrast of blood vessels or tissues in Magnetic Resonance Imaging (MRI). Its purpose is to improve the accuracy of medical imaging diagnostics.
Eobi-DTPA selectively distributes in specific tissues or blood vessels in the body, highlighting these areas during imaging. This helps physicians easily distinguish between normal tissues and lesions. The contrast effect improves the resolution of images and the accuracy of diagnosis.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other contrast agents, Eobi-DTPA has a high affinity for specific tissues, thereby improving image quality. It also has a relatively safe profile and is used with caution in patients with impaired kidney function. This characteristic distinguishes it from other metal ion-based contrast agents.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.